{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:37:03Z","timestamp":1768624623172,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijrobp.2023.07.036","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T22:51:37Z","timestamp":1691103097000},"page":"85-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Dosimetric Correlation Between Radiation Dose to Bone and Reduction of Hemoglobin Levels After Radiation Therapy for Prostate Cancer"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3931-3314","authenticated-orcid":false,"given":"Jordan B.","family":"Fenlon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathlina M.","family":"Teague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savannah","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Shrieve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Tward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.07.036_bib0001","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2009.12.025","article-title":"Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow\u2013sparing pelvic IMRT","volume":"79","author":"Albuquerque","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: A phase 2 study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0003","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/IGC.0000000000000292","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: Comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy","volume":"24","author":"Hui","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0004","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fonc.2020.01179","article-title":"Comparison of hematologic toxicity and bone marrow compensatory response in head and neck vs. cervical cancer patients undergoing chemoradiotherapy","volume":"10","author":"Vitzthum","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2021.09.009","article-title":"Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: A systematic review","volume":"164","author":"Corbeau","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103497","article-title":"The impact of pelvic nodal radiotherapy on hematologic toxicity: A systematic review with focus on leukopenia, lymphopenia and future perspectives in prostate cancer treatment","volume":"168","author":"Iorio","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0007","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S1470-2045(18)30528-X","article-title":"Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG\/RTOG 9413): Long-term results of a randomised, phase 3 trial","volume":"19","author":"Roach","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0008","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00066-015-0841-3","article-title":"Early hematologic changes during prostate cancer radiotherapy predictive for late urinary and bowel toxicity","volume":"191","author":"Pinkawa","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0009","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1016\/S0167-8140(18)30937-X","article-title":"PV-0627: Hematologic toxicity after whole-pelvis irradiation: Results of a longitudinal observational study","volume":"127","author":"Rancati","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","article-title":"Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation","volume":"118","author":"Sini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0011","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/COC.0000000000000520","volume":"42","author":"Rice","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0012","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): An international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0013","series-title":"Stata Statistical Software: Release 14","year":"2015"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0014","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/0360-3016(86)90146-X","article-title":"The significance of anemia in clinical radiation therapy","volume":"12","author":"Bush","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1634\/theoncologist.7-6-492","article-title":"Impact of tumor hypoxia and anemia on radiation therapy outcomes","volume":"7","author":"Harrison","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijrobp.2005.04.049","article-title":"Anemia, tumor hypoxemia, and the cancer patient","volume":"63","author":"Varlotto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0017","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1200\/JCO.1995.13.12.2944","article-title":"Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy","volume":"13","author":"Sridhara","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0018","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0019","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/cncr.22029","article-title":"The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer","volume":"107","author":"Beer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0021","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0360-3016(89)90277-0","article-title":"The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate","volume":"16","author":"Dunphy","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0022","first-page":"5173","article-title":"Prognostic factors in patients with advanced stage prostate cancer","volume":"45","author":"Emrich","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0023","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/1097-0142(19900615)65:12<2758::AID-CNCR2820651225>3.0.CO;2-6","article-title":"Analysis of prognostic factors in disseminated prostatic cancer. An update","volume":"65","author":"Mulders","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0024","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2004.07.710","article-title":"Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer","volume":"61","author":"Prosnitz","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0025","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/1097-0142(20001101)89:9<2018::AID-CNCR19>3.0.CO;2-Y","article-title":"Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: An Eppendorf pO(2) study","volume":"89","author":"Movsas","year":"2000","journal-title":"Cancer"},{"issue":"6, part 1","key":"10.1016\/j.ijrobp.2023.07.036_bib0026","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/01.ju.0000147771.92104.83","article-title":"Prognostic value of anemia in newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894","volume":"172","author":"Beer","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0027","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1200\/JCO.1994.12.9.1868","article-title":"Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: A Southwest Oncology Group report","volume":"12","author":"Hussain","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0028","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0360-3016(98)00482-9","article-title":"FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy","volume":"43","author":"Logsdon","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jso.2930440307","article-title":"Radiation therapy in the treatment of cervical cancer: The University of Chicago\/Michael Reese Hospital experience","volume":"44","author":"Rader","year":"1990","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(98)00375-7","article-title":"Clinical radiobiology of glottic T1 squamous cell carcinoma","volume":"43","author":"Skladowski","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0031","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0167-8140(92)80126-4","article-title":"The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma","volume":"23","author":"van Acht","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0032","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(97)00308-8","article-title":"Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx","volume":"38","author":"Tarnawski","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0033","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","article-title":"Epoetin Alfa Study Group. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Littlewood","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0034","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/94.16.1211","article-title":"Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy","volume":"94","author":"Vansteenkiste","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0036","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/aja.2011.102","article-title":"Hematological changes during androgen deprivation therapy","volume":"14","author":"Grossmann","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0037","first-page":"28","article-title":"Androgen deprivation therapy and the risk of anemia in men with prostate cancer","author":"Hicks","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0038","unstructured":"US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0. Available at:https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed August 23, 2023."},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0039","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2005-07-3046","article-title":"The definition of anemia: What is the lower limit of normal of the blood hemoglobin concentration?","volume":"107","author":"Beutler","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.rpor.2017.02.010","article-title":"Radiobiology of stereotactic body radiation therapy (SBRT)","volume":"22","author":"Maci\u00e0","year":"2017","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2023.07.036_bib0041","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1088\/0031-9155\/51\/11\/009","article-title":"Fitting the linear\u2013quadratic model to detailed data sets for different dose ranges","volume":"51","author":"Garcia","year":"2006","journal-title":"Phys Med Biol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623077246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623077246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:10:47Z","timestamp":1759745447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623077246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0360301623077246"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.07.036","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Dosimetric Correlation Between Radiation Dose to Bone and Reduction of Hemoglobin Levels After Radiation Therapy for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}